European Institute of Science AB Logo

European Institute of Science AB

Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.

EURI B | SPGR

Overview

Corporate Details

ISIN(s):
SE0020357440 (+1 more)
LEI:
549300VADF7E2RMTRE02
Country:
Sweden
Address:
Ideongatan 1A, 223 70 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

European Institute of Science AB is a manufacturer of diagnostic assays and point-of-care (POC) instrumentation, with a primary focus on the veterinary health market. The company develops, produces, and sells solutions for canine, feline, and equine diagnostics, targeting veterinary professionals in clinical laboratories and POC settings. Key products include the TurboReader™, a compact nephelometric diagnostic reader, and a portfolio of rapid in-vitro assays for monitoring inflammation and other health conditions. The company also distributes third-party veterinary products in Scandinavia. Founded in 1990, it has a history as a research and development hub that has successfully spun off multiple public med-tech and biotech companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-10-03 20:01
Major Shareholding Notification
English 33.4 KB
2009-02-11 11:09
Annual / Quarterly Financial Statement
Swedish 323.6 KB
2009-02-02 14:29
Delisting Announcement
Swedish 255.8 KB
2008-10-31 09:45
Quarterly Report
Swedish 328.3 KB
2008-09-30 13:47
Regulatory News Service
Swedish 28.4 KB
2008-08-29 10:36
Interim Report
Swedish 322.1 KB
2008-06-30 08:05
Regulatory News Service
Swedish 259.1 KB
2008-05-16 15:08
Post-Annual General Meeting Information
Swedish 258.5 KB
2008-04-29 00:00
Annual Report
Swedish 687.0 KB
2008-04-18 12:45
Pre-Annual General Meeting Information
Swedish 45.8 KB
2008-04-14 09:22
Quarterly Report
Swedish 320.2 KB
2008-01-21 10:46
Earnings Release
Swedish 320.6 KB
2007-10-26 08:14
Quarterly Report
Swedish 322.1 KB
2007-10-16 10:47
Earnings Release
Swedish 257.6 KB
2007-08-31 11:52
Interim Report
Swedish 320.1 KB

Automate Your Workflow. Get a real-time feed of all European Institute of Science AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for European Institute of Science AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-27 Pharmart AB Other Sell 9,341 19,709.51 SEK

Peer Companies

Company Country Ticker View
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea 204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary GWPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.